Inventor · disambiguated record
Robin Cooper
Also filed as: COOPER ROBIN · COOPER ROBIN D G · COOPER ROBIN DAVID GREY · KOPPEL GARY A
51 granted patents·1 pending application·854 citations·filing 1974–2021
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US7491732B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 17, 2009·105 cites·6 claims
- 0297US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0397US4144232ASubstituted azetidin-2-one antibioticsLILLY CO ELI·Filed 1977·Granted Mar 13, 1979·62 cites·32 claims
- 0496US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 0596US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 0695US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 0795US8193197B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Jun 5, 2012·17 cites·38 claims
- 0894US7557207B2Spiro 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 7, 2009·35 cites·24 claims
- 0994US5840684AGlycopeptide antibiotic derivativesLILLY CO ELI·Filed 1995·Granted Nov 24, 1998·134 cites·7 claims
- 1093US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 1191US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 1291US7851480B2Spiro 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Dec 14, 2010·18 cites·7 claims
- 1390US8304422B2Compositions and methods for inhibition of the JAK pathwayATUEGBU ANDY·Filed 2010·Granted Nov 6, 2012·26 cites·22 claims
- 1489US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 1588US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 1687US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 1785US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 1885US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
- 1985US4734498A3β-succinimidoazetidinones as chiral intermediatesLILLY CO ELI·Filed 1986·Granted Mar 29, 1988·21 cites·20 claims
- 2084US5916873ATeicoplanin derivativesLILLY CO ELI·Filed 1998·Granted Jun 29, 1999·71 cites·9 claims
- 2183US4772694AChiral 3-(1,2,5-trisubstituted imidazolidinone) azetidinone antibiotic intermediatesLILLY CO ELI·Filed 1986·Granted Sep 20, 1988·19 cites·16 claims
- 2283US3956292A7-(α-FUROYLUREIDOARYL AND CYCLOHEXADIENYLACETAMIDO) CEPHALOSPORIN ANTIBIOTICSLILLY CO ELI·Filed 1975·Granted May 11, 1976·11 cites·16 claims
- 2380US11827628B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·19 claims
- 2479US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 2578US3946003AHydroxy substituted phenylglycylamido-3-heterocyclic thiomethyl cephalosporinsLILLY CO ELI·Filed 1974·Granted Mar 23, 1976·9 cites·3 claims
- 2675US5843889AGlycopeptide antibiotic derivativesLILLY CO ELI·Filed 1997·Granted Dec 1, 1998·40 cites·9 claims
- 2774US4355172AProcess for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivativesLILLY CO ELI·Filed 1977·Granted Oct 19, 1982·9 cites·10 claims
- 2870US5919756AAmidesLILLY CO ELI·Filed 1997·Granted Jul 6, 1999·21 cites·14 claims
- 2968US9040543B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·0 cites·17 claims
- 3068US5977062AGlycopeptide antibiotic derivativesLILLY CO ELI·Filed 1998·Granted Nov 2, 1999·24 cites·34 claims
- 3160US8729087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2012·Granted May 20, 2014·0 cites·22 claims
- 3256US4115383AAlkoxycarbonyl-ethylthio-azetidinones and process for their preparationLILLY CO ELI·Filed 1976·Granted Sep 19, 1978·3 cites·4 claims
- 3350US4203896AAcetoxy azetidin-2-one antibiotics via thiazolidine ring cleavageLILLY CO ELI·Filed 1978·Granted May 20, 1980·2 cites·7 claims
- 3449US4224442A7-Ureido acetamido substituted cephalosporin antibioticsLILLY CO ELI·Filed 1975·Granted Sep 23, 1980·2 cites·20 claims
- 3545US6683176B2Intermediates for and synthesis of 3-methylene cephamsFiled 2001·Granted Jan 27, 2004·0 cites·20 claims
- 3645US4482553ABenzothienylglycyl cephalosporin derivativesLILLY CO ELI·Filed 1983·Granted Nov 13, 1984·2 cites·20 claims
- 3745US4133808A4-(Formylthio)azetidinones and ozonization process thereforLILLY CO ELI·Filed 1977·Granted Jan 9, 1979·1 cites·7 claims
- 3845US4048157A4(Formylthio)-azetidin-2-ones and ozonization process thereforLILLY CO ELI·Filed 1975·Granted Sep 13, 1977·1 cites·9 claims
- 3944US6908996B2Compounds and method for preparing 3-methylcephamsIMP COLLEGE OF LONDON·Filed 2003·Granted Jun 21, 2005·0 cites·7 claims
- 4043US4039535A7-[α-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICSLILLY CO ELI·Filed 1976·Granted Aug 2, 1977·1 cites·7 claims
- 4142US4490370ANaphthylglycyl cephalosporin derivativesLILLY CO ELI·Filed 1983·Granted Dec 25, 1984·2 cites·40 claims
- 4241US4518531AAllylic chlorination process and compounds prepared therebyLILLY CO ELI·Filed 1983·Granted May 21, 1985·1 cites·10 claims
- 4341US2005239751A1Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4440US4127568AProcess for 3β-aminoazetidin-2-onesLILLY CO ELI·Filed 1977·Granted Nov 28, 1978·1 cites·8 claims
- 4539US4430268AAllylic chlorination processLILLY CO ELI·Filed 1980·Granted Feb 7, 1984·1 cites·12 claims
- 4639US4158004AProcess for antibiotic FR 1923 and related compoundsLILLY CO ELI·Filed 1976·Granted Jun 12, 1979·4 cites·9 claims
- 4735US4226767AIntermediates for 3-aminoazetidin-2-onesLILLY CO ELI·Filed 1979·Granted Oct 7, 1980·0 cites·5 claims
- 4835US4180507A4-Oxa 2,6 diazabicycloheptane derivativesLILLY CO ELI·Filed 1978·Granted Dec 25, 1979·0 cites·3 claims
- 4934US4243587AProcess for 3β-aminoazetidin-2-onesLILLY CO ELI·Filed 1979·Granted Jan 6, 1981·0 cites·2 claims
- 5030US4468514APreparation of 3-bromocephalosporins from thiazoline azetidinonesLILLY CO ELI·Filed 1982·Granted Aug 28, 1984·0 cites·9 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robin Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →